Skip to main content
DiabetesGenetics

What this study is

This program collects genetic and health information to help doctors choose the right medications for patients.

Study details

Official title
The Texas Interprofessional Pharmacogenomics Registry and Repository
Sponsor
Texas A&M University
Conditions
Diabetes · Cholesterol · Cancer · Blood Pressure Disorders · Heart Disease · Respiratory Ilness · COPD · Adverse Drug Reaction (ADR) · Poly Pharmacy
Enrolling
3,000 people
Starts
2025-11
Est. completion
2029-11
Record
View on ClinicalTrials.gov ↗